The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula I:
where R1, R2, R3, U and V are defined below and to pharmaceutically acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKβ) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
[EN] DISUBSTITUTED CYCLOPENTANE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE DE CYCLOPENTANE DISUBSTITUÉS
申请人:ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD
公开号:WO2022135365A1
公开(公告)日:2022-06-30
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to cyclin dependent kinases (CDKs). The compounds herein are typically CDK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as cancer.
Baranov, S. V.; Mochalin V. B., Journal of Organic Chemistry USSR (English Translation), 1981, vol. 17, p. 951 - 953
作者:Baranov, S. V.、Mochalin V. B.
DOI:——
日期:——
Palladium(0)-catalyzed reaction of (Z)-2-butene-1,4-diyl bis(methyl carbonate) and (Z)-2-butene-1,4-diyl diacetate with bifunctional nitrogen nucleophiles
作者:Tetsuo Tsuda、Takao Kiyoi、Takeo Saegusa
DOI:10.1021/jo00297a077
日期:1990.5
TSUDA, TETSUO;KIYOI, TAKAO;SAEGUSA, TAKEO, J. ORG. CHEM., 55,(1990) N0, C. 3388-3390